Product Information

FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5252 per EA under NDC 65862030901. Its NADAC has been published 557 times since Nov 28, 2013.

FDA first approved this application on Jul 9, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB

Fosinopril Sodium and Hydrochlorothiazide
$0.5252per EA

Strength

20; 12.5 mg/1; mg/1

NDC

65862030901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079245

FDA Approved

7/9/2009

TE Code

AB

On Market Since

7/9/2009

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 557 times since Nov 28, 2013, and over the history we have for it it has declined 39.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5252 per EA
All-time high$1.1386 (Jul 15, 2015)
All-time low$0.4107 (Oct 18, 2023)
52-week high$0.6291
52-week low$0.4313
Median price$0.8286
Average price$0.7903
Largest weekly change+37.8% (Jun 17, 2015)
Weeks tracked557
Tracking sinceNov 28, 2013

Price History

1W

+8.5%

1M

+8.5%

3M

+20.9%

6M

+1.8%

1Y

-6.8%

3Y

-18.8%

5Y

-26.7%

All

-39.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.5252 per EA (NDC 65862030901), effective Aug 19, 2026.

How has the price of FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 39.9%. It has been tracked across 557 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Since Nov 28, 2013, the NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.4107 (Oct 18, 2023) to a high of $1.1386 (Jul 15, 2015), with a median of $0.8286 per EA.

Are there cheaper alternatives to FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 65862030901) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.